Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$203.52 - $273.43 $427,392 - $574,203
2,100 Added 175.0%
3,300 $894,000
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $427,752 - $620,984
-2,600 Reduced 68.42%
1,200 $283,000
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $408,324 - $456,981
2,100 Added 123.53%
3,800 $744,000
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $110,226 - $126,150
600 Added 54.55%
1,700 $357,000
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $19,189 - $25,992
100 Added 10.0%
1,100 $222,000
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $354,798 - $450,126
-1,800 Reduced 64.29%
1,000 $217,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $510,832 - $701,512
2,800 New
2,800 $551,000
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $357,714 - $506,954
1,400 New
1,400 $398,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.64B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.